Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Second, we are encouraged by the early momentum we are seeing as a result of the targeted programs implemented in Q2 to provide more operational flexibility to our U.S |
| On a regional level, the improved margin speaks to our continued focus on higher-margin US operations |
| We were pleased to see improvements in revenue trends in the US during the third quarter, where sales declined modestly on a year-over-year basis but increased 14% on a quarter-over-quarter basis in Q3 |
| Despite the tougher operating environment, there are early signs, particularly in the US that our efforts to reposition the business and to focus on key strategic and operational initiatives are beginning to bear fruit, including: first, we are pleased to report that cash system sales represented 69% of total systems and subscription sales compared to 59% in the prior year period |
| The new Versa Pro provides our customers with an enhanced user experience and superior clinical performance |
| Cash system sales to US customers increased 12% year-over-year in Q3 and have increased more than 40% over the first nine months of 2023, which reflects the team's strong execution towards our strategic priority to transition the company to higher quality cash revenues |
| Fourth, as discussed on our second quarter call, we've advanced certain new product pipeline projects ahead of expectations, and are pleased with the significant progress made in new product introductions in recent months |
| With a target of having our new distributor partners in key markets identified, signed up and up and running in the majority of our key international markets by early next year, we expect to be well positioned for a return to growth in 2024 |
| We continue to expect improvements to overall sales productivity and customer responsiveness in the challenging environment that many of our customers are facing |
| Importantly, despite the softer than expected revenue results this year, the continued focus on restructuring and rightsizing the business, reducing cost and simplifying the organization are progressing well ahead of expectations |
| Specifically, we are transitioning the company to higher quality cash revenues, exiting unprofitable direct operations in certain international markets and implementing a series of restructuring activities, which altogether are expected to enhance the cash flow profile of the business and accelerate the path to long-term sustainable profitability and growth |
| We believe the reduction in expenses and cash used in operations to-date represents the clearest evidence that we are on the right track towards our goal of enhancing the cash flow profile of the business and accelerating the path to long-term sustainable profitability and growth |
| Venus AI captures our strong commitment towards growing our global brand, focusing on emerging technologies and services, partnering with customers to build smarter practices and customizable treatments |
| Notably, the decision we made in Q2 to target additional cost containment initiatives, including identifying areas where we can implement phased R&D investments has helped protect our near-term cash runway and accelerate our path to cash flow breakeven in the second half of 2024 |
| We see this as an important near-term growth opportunity for new customers and an attractive upgrade opportunity for existing users |
| We are pleased with the progress we have made in our strategic turnaround plan in 2023 |
| Nonetheless, we delivered another strong quarter of working capital performance with more than $2.5 million of cash generated from working capital in the period |
| But we are pleased with how the gross margins are progressing |
| We are executing the strategic plan we outlined at the start of the year on or ahead of expectations |
| First, our cost reduction and cash management initiatives designed to accelerate our path to cash flow breakeven are progressing at or ahead of expectations |
| Further, by staying connected to our customers, we can start to leverage real-time data across our growing network of connected devices to uncover the meaningful business insights that define the best in practice performance and fuel the next generation of aesthetic device technologies |
| After receiving FDA 510(k) clearance in September, we are pleased to announce the U.S |
| But in doing that, we've actually still been able to maintain and accelerate others |
| So it's a great installed base to build off of |
| The system's ability to support 10 different applicators addresses the growing demand for multimodal solutions in aesthetic clinics and med spas and offers a complete rejuvenation solution for addressing tone, texture and tightness |
| However, our team is executing well despite these unexpected challenges |
| And based on better-than-expected expense performance in the first nine months of 2023 and our updated expense assumptions for Q4, we now expect GAAP operating expenses for the full year 2023 period in the range of approximately $81 million to $83 million compared to our prior guidance of $87 million to $89 million |
| But there's also great opportunities for those that have initial system to either expand with the new system, to have the higher power via MD and BC Incorporated or to add to their practice |
| Second, at the low end of our full year 2023 revenue range, we now expect gross margins of approximately 68%, up roughly 200 basis points year-over-year as compared to prior guidance assumptions, which called for 67% gross margins year-over-year in 2023 |
| Restructuring our debt obligations represents the achievement of an important milestone for the company, one that reduces our total debt, deferred principal and interest payments and lowers our near-term cash needs |
| Statement |
|---|
| We reported GAAP revenue of $17.6 million, down 18% year-over-year |
| Macroeconomic headwinds continue to pressure the aesthetic sector as a whole, with higher interest rates affecting our customers' ability to finance new capital equipment purchases and deals are taking longer to close |
| Our international revenue results were impacted by the company's decision to exit three unprofitable direct markets in the past year, as well as the general macroeconomic headwinds that impacted customer access to capital |
| First, the 20% decline in revenue at the low end of our full year guidance range continues to reflect the expectation that cash system sales represent approximately 70% of total subscription and system sales for full year 2023 compared to approximately 58% for full year 2022 |
| While our third quarter total revenue declined on a year-over-year basis the majority of that decline can be attributed to our accelerated restructuring activities in certain international markets |
| Candidly, the macro environment has represented more of a headwind than we had contemplated |
| The decrease in total revenue by region was driven by a 34% year-over-year in international revenue and a 5% decrease year-over-year in United States revenue |
| The change in gross profit was primarily due to a decrease in revenue in our international markets driven by the accelerated exit from unprofitable direct markets |
| Similar to what we have discussed on our recent earnings calls, the year-over-year revenue decline is a direct result of the strategic initiatives we are executing this year |
| Our total revenue guidance for 2023 now assumes year-over-year headwinds to our revenue growth from lower lease revenue in favor of cash system sales of approximately $15 million versus $16 million previously and the impact related to the acceleration of strategic initiatives we are implementing in our international business this year of approximately $17 million compared to an $8 million headwind assumed at the low end of our prior guidance range |
| The company continues to expect total revenue for the 12 months ending December 31, 2023, in the range of $80 million to $82 million representing a decrease in the range of approximately 18% to 20% year-over-year |
| The decrease in total revenue by product category was driven by a 39% decrease in lease revenue, a 20% decrease in products other revenue, a 6% decrease in products systems revenue partially offset by a 15% increase in services revenue |
| Gross profit decreased $1.2 million or 9% to $12.2 million |
| I'm wondering what's driving maybe some of the resiliency there? And you mentioned some macroeconomic headwinds that are starting to impact customer access to capital |
| I think what's new is that that customer buying patterns, especially when it comes to kind of the deal cycle is becoming longer and longer because many customers are shopping deals, which is -- and certainly, we likely saw -- and as Dominic mentioned, certainly cash collections slip from third quarter into fourth quarter |
| The change in gross margin was primarily due to significant inventory write-offs in the third quarter of 2022, which should not repeat this quarter, and a $0.8 million foreign exchange headwind as a result of certain foreign currencies depreciating relative to the US dollar |
| Finally, we continue to expect our updated total revenue guidance and supporting modeling assumptions across the P&L for 2023 to result in a reduction in our cash used from operations of more than 50% year-over-year |
| In addition, the inflationary economy has impacted higher price procedures such as those related to our hair business |
| The total operating loss was $6.8 million compared to $11.4 million in the third quarter of 2022 |
| Adjusted EBITDA loss for the third quarter of 2023 was $4.6 million, compared to $7.7 million for the third quarter of 2022 |
Please consider a small donation if you think this website provides you with relevant information